Tuberculous gumma: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Trafermin''' is a synthetic form of [[human fibroblast growth factor]] (FGF), a substance that is naturally present in the body and plays a crucial role in wound healing and tissue repair. It is used in medicine to promote the healing of skin ulcers and other wounds.
{{SI}}
 
{{Infobox medical condition
== Mechanism of Action ==
| name                    = Tuberculous gumma
 
| image                  = [[File:Tuberculoid_Gumma2.png|250px]]
Trafermin works by stimulating the growth of cells involved in wound healing, particularly fibroblasts. These cells produce collagen and other proteins that form the structure of skin and other tissues. By promoting the proliferation of fibroblasts, trafermin helps to speed up the healing process.
| caption                = Tuberculous gumma on the skin
 
| field                  = [[Infectious disease]]
== Uses ==
| synonyms                = Metastatic tuberculous abscess
 
| symptoms                = [[Skin lesion]], [[ulcer]], [[abscess]]
Trafermin is used in the treatment of chronic skin ulcers, such as those caused by [[diabetes]] or [[venous insufficiency]]. It is also used to promote healing in wounds caused by burns or surgery.
| complications          = [[Scarring]], [[secondary infection]]
 
| onset                  = Variable
== Side Effects ==
| duration                = Chronic
 
| causes                  = [[Mycobacterium tuberculosis]]
Like all medicines, trafermin can cause side effects. These may include redness, swelling, or pain at the site of application. In rare cases, it can cause allergic reactions.
| risks                  = [[Immunocompromised]] state, [[HIV/AIDS]], [[malnutrition]]
 
| diagnosis              = [[Biopsy]], [[culture]], [[PCR]]
== Contraindications ==
| differential            = [[Sporotrichosis]], [[cutaneous leishmaniasis]], [[syphilis]]
 
| prevention              = [[BCG vaccine]], [[tuberculosis control]]
Trafermin should not be used in people who are allergic to it or to any of its ingredients. It should also not be used in people with certain types of skin cancer, as it could potentially stimulate the growth of cancer cells.
| treatment              = [[Antitubercular therapy]]
 
| medication              = [[Isoniazid]], [[rifampicin]], [[ethambutol]], [[pyrazinamide]]
== See Also ==
| prognosis              = Good with treatment
 
| frequency              = Rare
* [[Fibroblast Growth Factor]]
| deaths                  = Rare with treatment
* [[Wound Healing]]
}}
* [[Skin Ulcer]]
{{Short description|A rare form of cutaneous tuberculosis}}
 
'''Tuberculous gumma''', also known as '''metastatic tuberculous abscess''', is a rare form of [[cutaneous tuberculosis]]. It is characterized by the formation of soft, tumor-like masses on the skin, which are caused by the hematogenous spread of [[Mycobacterium tuberculosis]] from a primary focus elsewhere in the body.
[[Category:Medicine]]
== Pathophysiology ==
[[Category:Pharmacology]]
Tuberculous gumma occurs when [[Mycobacterium tuberculosis]] bacteria spread through the bloodstream and form abscesses in the skin. This condition is more likely to occur in individuals with a compromised [[immune system]], such as those with [[HIV/AIDS]] or those undergoing [[immunosuppressive therapy]]. The bacteria can form nodules that eventually ulcerate, leading to the characteristic lesions of tuberculous gumma.
== Clinical Presentation ==
Patients with tuberculous gumma typically present with painless, firm nodules on the skin. These nodules can vary in size and may become ulcerated over time. The lesions are often found on the extremities, but can occur anywhere on the body. The skin overlying the nodules may appear normal or erythematous.
== Diagnosis ==
The diagnosis of tuberculous gumma is confirmed through a combination of clinical examination, [[skin biopsy]], and microbiological studies. A biopsy of the lesion typically shows caseating granulomas, which are indicative of tuberculosis. [[Polymerase chain reaction]] (PCR) and culture of the biopsy material can be used to identify [[Mycobacterium tuberculosis]].
== Treatment ==
The treatment of tuberculous gumma involves the use of [[antitubercular therapy]]. The standard regimen includes a combination of [[isoniazid]], [[rifampicin]], [[ethambutol]], and [[pyrazinamide]] for an initial period, followed by isoniazid and rifampicin for a continuation phase. The duration of treatment is typically 6 to 12 months, depending on the severity of the disease and the patient's response to therapy.
== Prognosis ==
With appropriate treatment, the prognosis for patients with tuberculous gumma is generally good. The lesions usually resolve with antitubercular therapy, although scarring may occur. Early diagnosis and treatment are crucial to prevent complications and the spread of the disease.
== See also ==
* [[Tuberculosis]]
* [[Cutaneous tuberculosis]]
* [[Mycobacterium tuberculosis]]
* [[Granuloma]]
[[Category:Tuberculosis]]
[[Category:Dermatology]]
[[Category:Dermatology]]
{{stub}}

Latest revision as of 19:38, 8 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Tuberculous gumma
File:Tuberculoid Gumma2.png
Synonyms Metastatic tuberculous abscess
Pronounce N/A
Specialty N/A
Symptoms Skin lesion, ulcer, abscess
Complications Scarring, secondary infection
Onset Variable
Duration Chronic
Types N/A
Causes Mycobacterium tuberculosis
Risks Immunocompromised state, HIV/AIDS, malnutrition
Diagnosis Biopsy, culture, PCR
Differential diagnosis Sporotrichosis, cutaneous leishmaniasis, syphilis
Prevention BCG vaccine, tuberculosis control
Treatment Antitubercular therapy
Medication Isoniazid, rifampicin, ethambutol, pyrazinamide
Prognosis Good with treatment
Frequency Rare
Deaths Rare with treatment


A rare form of cutaneous tuberculosis


Tuberculous gumma, also known as metastatic tuberculous abscess, is a rare form of cutaneous tuberculosis. It is characterized by the formation of soft, tumor-like masses on the skin, which are caused by the hematogenous spread of Mycobacterium tuberculosis from a primary focus elsewhere in the body.

Pathophysiology[edit]

Tuberculous gumma occurs when Mycobacterium tuberculosis bacteria spread through the bloodstream and form abscesses in the skin. This condition is more likely to occur in individuals with a compromised immune system, such as those with HIV/AIDS or those undergoing immunosuppressive therapy. The bacteria can form nodules that eventually ulcerate, leading to the characteristic lesions of tuberculous gumma.

Clinical Presentation[edit]

Patients with tuberculous gumma typically present with painless, firm nodules on the skin. These nodules can vary in size and may become ulcerated over time. The lesions are often found on the extremities, but can occur anywhere on the body. The skin overlying the nodules may appear normal or erythematous.

Diagnosis[edit]

The diagnosis of tuberculous gumma is confirmed through a combination of clinical examination, skin biopsy, and microbiological studies. A biopsy of the lesion typically shows caseating granulomas, which are indicative of tuberculosis. Polymerase chain reaction (PCR) and culture of the biopsy material can be used to identify Mycobacterium tuberculosis.

Treatment[edit]

The treatment of tuberculous gumma involves the use of antitubercular therapy. The standard regimen includes a combination of isoniazid, rifampicin, ethambutol, and pyrazinamide for an initial period, followed by isoniazid and rifampicin for a continuation phase. The duration of treatment is typically 6 to 12 months, depending on the severity of the disease and the patient's response to therapy.

Prognosis[edit]

With appropriate treatment, the prognosis for patients with tuberculous gumma is generally good. The lesions usually resolve with antitubercular therapy, although scarring may occur. Early diagnosis and treatment are crucial to prevent complications and the spread of the disease.

See also[edit]